![Structural Basis of Selective Human Indoleamine‐2,3‐dioxygenase 1 (hIDO1) Inhibition - Kassab - 2021 - ChemMedChem - Wiley Online Library Structural Basis of Selective Human Indoleamine‐2,3‐dioxygenase 1 (hIDO1) Inhibition - Kassab - 2021 - ChemMedChem - Wiley Online Library](https://chemistry-europe.onlinelibrary.wiley.com/cms/asset/e54c0e7e-4db3-44e2-8ffc-c36610a9a562/cmdc202100253-toc-0001-m.jpg)
Structural Basis of Selective Human Indoleamine‐2,3‐dioxygenase 1 (hIDO1) Inhibition - Kassab - 2021 - ChemMedChem - Wiley Online Library
Indoximod opposes the immunosuppressive effects mediated by IDO and TDO via modulation of AhR function and activation of mTORC1 | Oncotarget
![Proposed mechanism for formation of ¹O2 by IDO1 plus H2O2 and chemical... | Download Scientific Diagram Proposed mechanism for formation of ¹O2 by IDO1 plus H2O2 and chemical... | Download Scientific Diagram](https://www.researchgate.net/publication/331085746/figure/fig9/AS:731591680733185@1551436457080/Proposed-mechanism-for-formation-of-O2-by-IDO1-plus-H2O2-and-chemical-synthesis-of.jpg)
Proposed mechanism for formation of ¹O2 by IDO1 plus H2O2 and chemical... | Download Scientific Diagram
![Incyte and Merck to Advance Clinical Development Program Investigating the Combination of Epacadostat with KEYTRUDA® (pembrolizumab) | Business Wire Incyte and Merck to Advance Clinical Development Program Investigating the Combination of Epacadostat with KEYTRUDA® (pembrolizumab) | Business Wire](https://mms.businesswire.com/media/20170109005409/en/3588/23/Incyte_2CPos_RGB.jpg)
Incyte and Merck to Advance Clinical Development Program Investigating the Combination of Epacadostat with KEYTRUDA® (pembrolizumab) | Business Wire
![Characterization of Apo‐Form Selective Inhibition of Indoleamine 2,3‐Dioxygenase** - Ortiz‐Meoz - 2021 - ChemBioChem - Wiley Online Library Characterization of Apo‐Form Selective Inhibition of Indoleamine 2,3‐Dioxygenase** - Ortiz‐Meoz - 2021 - ChemBioChem - Wiley Online Library](https://chemistry-europe.onlinelibrary.wiley.com/cms/asset/313e2831-144a-4b36-992a-419c699d81a9/cbic202000298-toc-0001-m.png)
Characterization of Apo‐Form Selective Inhibition of Indoleamine 2,3‐Dioxygenase** - Ortiz‐Meoz - 2021 - ChemBioChem - Wiley Online Library
![Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry - MedChemComm (RSC Publishing) DOI:10.1039/C7MD00109F Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry - MedChemComm (RSC Publishing) DOI:10.1039/C7MD00109F](https://pubs.rsc.org/image/article/2017/MD/c7md00109f/c7md00109f-f1_hi-res.gif)
Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry - MedChemComm (RSC Publishing) DOI:10.1039/C7MD00109F
Volker Schulz on Twitter: "So, will $NLNK's #indoximod, the #IDO inhibitor (that isn't really an IDO inhibitor) succeed, where #epacadostat failed? $INCY $MRK https://t.co/soLajZYdiR" / Twitter
![Frontiers | Updates in the Clinical Development of Epacadostat and Other Indoleamine 2,3-Dioxygenase 1 Inhibitors (IDO1) for Human Cancers | Oncology Frontiers | Updates in the Clinical Development of Epacadostat and Other Indoleamine 2,3-Dioxygenase 1 Inhibitors (IDO1) for Human Cancers | Oncology](https://www.frontiersin.org/files/Articles/382730/fonc-08-00423-HTML/image_m/fonc-08-00423-g001.jpg)
Frontiers | Updates in the Clinical Development of Epacadostat and Other Indoleamine 2,3-Dioxygenase 1 Inhibitors (IDO1) for Human Cancers | Oncology
![Frontiers | Inhibition Mechanism of Indoleamine 2, 3-Dioxygenase 1 (IDO1) by Amidoxime Derivatives and Its Revelation in Drug Design: Comparative Molecular Dynamics Simulations | Molecular Biosciences Frontiers | Inhibition Mechanism of Indoleamine 2, 3-Dioxygenase 1 (IDO1) by Amidoxime Derivatives and Its Revelation in Drug Design: Comparative Molecular Dynamics Simulations | Molecular Biosciences](https://www.frontiersin.org/files/MyHome%20Article%20Library/520730/520730_Thumb_400.jpg)
Frontiers | Inhibition Mechanism of Indoleamine 2, 3-Dioxygenase 1 (IDO1) by Amidoxime Derivatives and Its Revelation in Drug Design: Comparative Molecular Dynamics Simulations | Molecular Biosciences
![Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy | Journal of Hematology & Oncology | Full Text Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-021-01080-8/MediaObjects/13045_2021_1080_Fig3_HTML.png)
Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy | Journal of Hematology & Oncology | Full Text
![JCM | Free Full-Text | Anti-PD-1 and Novel Combinations in the Treatment of Melanoma—An Update | HTML JCM | Free Full-Text | Anti-PD-1 and Novel Combinations in the Treatment of Melanoma—An Update | HTML](https://www.mdpi.com/jcm/jcm-09-00223/article_deploy/html/images/jcm-09-00223-g001.png)